CoChat

Gene therapy: advances, challenges and perspectives

Open access
Gonçalves, Giulliana Augusta Rangel, Paiva, Raquel de Melo Alves · 2017 · Einstein (São Paulo)

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

The ability to make site-specific modifications to the human genome has been an objective in medicine since the recognition of the gene as the basic unit of heredity. Thus, gene therapy is understood as the ability of genetic improvement through the correction of altered (mutated) genes or site-specific modifications that target therapeutic treatment. This therapy became possible through the advances of genetics and bioengineering that enabled manipulating vectors for delivery of extrachromosomal material to target cells. One of the main focuses of this technique is the optimization of delivery vehicles (vectors) that are mostly plasmids, nanostructured or viruses. The viruses are more often investigated due to their excellence of invading cells and inserting their genetic material. However, there is great concern regarding exacerbated immune responses and genome manipulation, especially in germ line cells. In vivo studies in in somatic cell showed satisfactory results with approved protocols in clinical trials. These trials have been conducted in the United States, Europe, Australia and China. Recent biotechnological advances, such as induced pluripotent stem cells in patients with liver diseases, chimeric antigen receptor T-cell immunotherapy, and genomic editing by CRISPR/Cas9, are addressed in this review.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1590/s1679-45082017rb4024

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Combination of stem cells and gene therapy
Figure 1 Combination of stem cells and gene therapyCC BY · PubMed Central
Figure 2 CRISPR Cas-9 system. The technique involves basically three molecules: one nuclease (generally wild type Cas-9 of Streptococcus pyogenes), an RNA guide (known as single guide RNA), and the target (frequently the DNA)
Figure 2 CRISPR Cas-9 system. The technique involves basically three molecules: one nuclease (generally wild type Cas-9 of Streptococcus pyogenes), an RNA guide (known as single guide RNA), and the target (frequently the DNA)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Research works printed but not linked: 4

  1. Mukherjee S, 2016, Genetic therapies: posthuman gene therapy
  2. Linden R, 2010, Gene therapy: what it is, what it is not and what it will be, Estud Av, 24, 31
  3. Parham P, 2009, Antigen recognition by T lymphocytes
  4. Vieira GV, 2016, Visão geral do mecanismo básico de ação

Cited by

See all 369

Metadata

Authors
Gonçalves, G. A. R., & Paiva, R. D. M. A.
Affiliations
  • Hospital Israelita Albert Einstein, Brazil
  • Hospital Israelita Albert Einstein (BR)
Venue
Einstein (São Paulo)
Published
2017-09
Volume
15
Issue
3
Pages
369-375
ISSN
1679-4508 (ISSN-L)
OpenAlex
W2944013917
Cited by
351
References
27
Citations by year
2026: 25 · 2025: 47 · 2024: 76 · 2023: 63 · 2022: 55 · 2021: 39 · 2020: 23 · 2019: 16 · 2018: 6
FWCI
8.17
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Einstein (São Paulo) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
  • Americanae (AECID Library) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
gene therapy, gene delivery vectors, viral vectors, plasmid vectors, genome editing, CRISPR/Cas9, induced pluripotent stem cells, liver disease, immune response to gene therapy, clinical trials, somatic cells, germline modification
MeSH terms
Gene Editing, Animals, Genetic Vectors, Humans, Receptors, Antigen, T-Cell, Genetic Therapy, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gene therapy: advances, challenges and perspectives. https://app.cochat.ai/papers/10.1590/s1679-45082017rb4024
The paper
Gonçalves, G. A. R., & Paiva, R. D. M. A. (2017). Gene therapy: advances, challenges and perspectives. Einstein (São Paulo). https://doi.org/10.1590/s1679-45082017rb4024

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.